Blue Pebble Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of Blue Pebble Ltd is ₹ 100 as of 13 Mar 15:31 . The P/E Ratio of Blue Pebble Ltd changed from 14 on March 2025 to 14 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 years The Market Cap of Blue Pebble Ltd changed from ₹ 70.99 crore on March 2025 to ₹ 70.99 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 years The revenue of Blue Pebble Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The ebitda of Blue Pebble Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The net profit of Blue Pebble Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The Dividend Payout of Blue Pebble Ltd changed from 4.03 % on March 2025 to 4.03 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Blue Pebble Ltd

Blue Pebble Ltd was originally incorporated as 'Blue Pebble Private Limited' on September 08, 2017 with the Registrar of Companies, Central Registration Centre.
Company converted into a Public Limited and the name was changed to 'Blue Pebble Limited' vide a fresh certificate of incorporation dated October 25, 2023 issued by the Registrar of Companies, Mumbai. Established in 2017, Blue Pebble specialized in spatial design and offers environmental branding solutions.
The Company provide printing and designing services, including theme-based designs, large format printing, vinyl printing, fabric printing, canvas printing, signage manufacturing, and 3D art installation.
It deal in sourcing and installation of curios, sculpture and artisanal hand paintings.
Through their graphics and signage solutions, Company transform workspace into functional environments that align with clients' corporate culture and values.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Blue Pebble Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Blue Pebble Ltd or Genomic Valley Biotech Ltd?

Market cap of Blue Pebble Ltd is 42 Cr while Market cap of Genomic Valley Biotech Ltd is 7 Cr

What are the key factors driving the stock performance of Blue Pebble Ltd and Genomic Valley Biotech Ltd?

The stock performance of Blue Pebble Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Pebble Ltd and Genomic Valley Biotech Ltd?

As of March 13, 2026, the Blue Pebble Ltd stock price is INR ₹105.2. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹25.13.

How do dividend payouts of Blue Pebble Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Blue Pebble Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.